Literature DB >> 27401791

How to diagnose NAFLD in 2016.

E Bugianesi1, C Rosso1, H Cortez-Pinto2.   

Abstract

Keywords:  Biomarkers; Biopsy; Fatty liver; Fibrosis; NAFLD; NASH; Screening; Steatosis

Mesh：

Year:  2016        PMID： 27401791     DOI： 10.1016/j.jhep.2016.05.038

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  14 in total

Review 1.  Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus.

Authors:  Giovanni Targher; Amedeo Lonardo; Christopher D Byrne
Journal:  Nat Rev Endocrinol       Date:  2017-12-29       Impact factor: 43.330

Review 2.  Beneficial Effects of Plant-Derived Natural Products on Non-alcoholic Fatty Liver Disease.

Authors:  Luis E Simental-Mendía; Claudia I Gamboa-Gómez; Fernando Guerrero-Romero; Mario Simental-Mendía; Adriana Sánchez-García; Mariana Rodríguez-Ramírez
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Effects of Dapagliflozin on Body Composition and Liver Tests in Patients with Nonalcoholic Steatohepatitis Associated with Type 2 Diabetes Mellitus: A Prospective, Open-label, Uncontrolled Study.

Authors:  Hiroshi Tobita; Shuichi Sato; Tatsuya Miyake; Shunji Ishihara; Yoshikazu Kinoshita
Journal:  Curr Ther Res Clin Exp       Date:  2017-07-08

4.  Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal.

Authors:  Bashu Dev Pardhe; Shreena Shakya; Anjeela Bhetwal; Jennifer Mathias; Puspa Raj Khanal; Roshan Pandit; Jyotsna Shakya; Hari Om Joshi; Sujan Babu Marahatta
Journal:  BMC Gastroenterol       Date:  2018-07-06       Impact factor: 3.067

Review 5.  Nonalcoholic fatty liver disease: Evolving paradigms.

Authors:  Amedeo Lonardo; Fabio Nascimbeni; Mauro Maurantonio; Alessandra Marrazzo; Luca Rinaldi; Luigi Elio Adinolfi
Journal:  World J Gastroenterol       Date:  2017-09-28       Impact factor: 5.742

Review 6.  Interleukin-1 Family Cytokines: Keystones in Liver Inflammatory Diseases.

Authors:  Louise Barbier; Maroua Ferhat; Ephrem Salamé; Aurélie Robin; André Herbelin; Jean-Marc Gombert; Christine Silvain; Alice Barbarin
Journal:  Front Immunol       Date:  2019-08-27       Impact factor: 7.561

7.  Increased liver echogenicity and liver enzymes are associated with extreme obesity, adolescent age and male gender: analysis from the German/Austrian/Swiss obesity registry APV.

Authors:  Susanne Greber-Platzer; Alexandra Thajer; Svenja Bohn; Annette Brunert; Felicitas Boerner; Wolfgang Siegfried; Andreas Artlich; Anja Moeckel; Hildegunde Waldecker-Krebs; Sophie Pauer; Reinhard W Holl
Journal:  BMC Pediatr       Date:  2019-09-12       Impact factor: 2.125

8.  FABP4 and MMP9 levels identified as predictive factors for poor prognosis in patients with nonalcoholic fatty liver using data mining approaches and gene expression analysis.

Authors:  Audrey Coilly; Christophe Desterke; Catherine Guettier; Didier Samuel; Franck Chiappini
Journal:  Sci Rep       Date:  2019-12-24       Impact factor: 4.379

9.  Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease.

Authors:  Taeang Arai; Masanori Atsukawa; Akihito Tsubota; Tadamichi Kawano; Mai Koeda; Yuji Yoshida; Tomohide Tanabe; Tomomi Okubo; Korenobu Hayama; Ai Iwashita; Norio Itokawa; Chisa Kondo; Keiko Kaneko; Chiaki Kawamoto; Tsutomu Hatori; Naoya Emoto; Etsuko Iio; Yasuhito Tanaka; Katsuhiko Iwakiri
Journal:  PLoS One       Date:  2019-11-13       Impact factor: 3.240

10.  Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease.

Authors:  Taeang Arai; Masanori Atsukawa; Akihito Tsubota; Keizo Kato; Hiroshi Abe; Hirotaka Ono; Tadamichi Kawano; Yuji Yoshida; Tomohide Tanabe; Tomomi Okubo; Korenobu Hayama; Ai Nakagawa-Iwashita; Norio Itokawa; Chisa Kondo; Keiko Kaneko; Naoya Emoto; Mototsugu Nagao; Kyoko Inagaki; Izumi Fukuda; Hitoshi Sugihara; Katsuhiko Iwakiri
Journal:  Sci Rep       Date:  2021-08-05       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.